INVO Bioscience Inc
NASDAQ:INVO
INVO Bioscience Inc
Other Current Assets
INVO Bioscience Inc
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
INVO Bioscience Inc
NASDAQ:INVO
|
Other Current Assets
$622.3k
|
CAGR 3-Years
57%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Current Assets
$1.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Current Assets
$991m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
5%
|
|
Stryker Corp
NYSE:SYK
|
Other Current Assets
$986m
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-4%
|
|
Abbott Laboratories
NYSE:ABT
|
Other Current Assets
$2.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-6%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Current Assets
$272.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
See Also
What is INVO Bioscience Inc's Other Current Assets?
Other Current Assets
622.3k
USD
Based on the financial report for Dec 31, 2023, INVO Bioscience Inc's Other Current Assets amounts to 622.3k USD.
What is INVO Bioscience Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
20%
Over the last year, the Other Current Assets growth was 228%. The average annual Other Current Assets growth rates for INVO Bioscience Inc have been 57% over the past three years , 20% over the past five years .